In this study GANT61 abrogated GLI function in the nucleus, blocked both GLI1- and GLI2- mediated transcription, inhibited GLI1-DNA binding, and demonstrated anti-tumor activity against human prostate cancer xenografts. The gene discussed is GLI2; the disease is prostate cancer.